Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
06/09/2005 | WO2005007852A3 Room temperature elution of nucleic acids |
06/09/2005 | WO2005003314A3 A method of selecting an active oligonucleotide predictive model |
06/09/2005 | WO2005001034A3 Rna-exit-channel: target and method for inhibition of bacterial rna polymerase |
06/09/2005 | WO2004110345A3 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
06/09/2005 | WO2004110246A3 Methods and compositions for diagnosing conditions associated with specific dna methylation patterns |
06/09/2005 | WO2004104170A3 Tools for detecting moraxella catarrhalis. |
06/09/2005 | WO2004087730A3 Method for producing diverse libraries of encoded polymers |
06/09/2005 | WO2004081177A3 Intracellular signaling pathways in diabetic subjects |
06/09/2005 | WO2004081021A3 Oligonucleotide mimetics |
06/09/2005 | WO2004072237A3 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydrogenase gene associated with altered lignification in loblolly pine |
06/09/2005 | WO2004025264A3 Rapidly degraded reporter fusion proteins |
06/09/2005 | US20050125852 Expression vector comprising nucleotide sequences coding protein and/or lipid kinases for use in generating animal models for prevention and treatment of pain, hypertensive, mood, inflammatory, skin, autoimmune, and psychological disorders |
06/09/2005 | US20050124800 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
06/09/2005 | US20050124791 Ion channel |
06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
06/09/2005 | US20050124585 Which contain phosphoramidate linkages; for retroviral or hepadnaviral therapy; for treatment of HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
06/09/2005 | US20050124584 Prodrugs of phosphonate nucleotide analogues |
06/09/2005 | US20050124583 Prodrugs of phosphonate nucleotide analogues |
06/09/2005 | US20050124572 Compositions and their uses directed to signal tranducers |
06/09/2005 | US20050124567 Apoptosis; controlling central nervous system disorders |
06/09/2005 | US20050124566 Using small nucleic acid as moderators of gene expression |
06/09/2005 | US20050124565 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
06/09/2005 | US20050124068 Hepatocellular carcinoma specific promoter and uses thereof |
06/09/2005 | US20050124058 System for housing/processing carrier and method for housing/processing carrier |
06/09/2005 | US20050124044 Interleukin-21 analogs |
06/09/2005 | US20050124040 Which produces N-alkyl-L-alanine from pyruvic acid and alkylamine or dialkylamine using NADPH and/or NADH as coenzyme; biosynthesis |
06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
06/09/2005 | US20050124038 Transfection of cartilage and matrices thereof in vitro |
06/09/2005 | US20050124000 Combinatorial strategies for polymer synthesis |
06/09/2005 | US20050123997 Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes |
06/09/2005 | US20050123986 Using aminated polypropylene as component in generating solid supports for detection preferential biopolymers; microarray biosynthesis |
06/09/2005 | US20050123984 Methods for generating cellulases |
06/09/2005 | US20050123972 Such as ligand binding and screening assays and signalling assays; chimeric chemokine receptor can also form a component of a chemokine receptor modulator design program |
06/09/2005 | US20050123959 Methods and kits for hybridizing multiple probe panels to nucleic acid samples |
06/09/2005 | US20050123950 Kit for use in detection and replication of microorganism polynucleotides; gene expression analysis; genomics; disease diagnosis |
06/09/2005 | US20050123943 Generating cDNA library from tumorigenic cell line; gene expression analysis and cancer detection |
06/09/2005 | US20050123941 Expression vector comprising nucleotide sequences coding polypeptide associated with fructo-oligosaccharide proteins for use in prevention or treatment of infections, diarrheal, cell proliferative and immune system disorders |
06/09/2005 | US20050123939 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
06/09/2005 | US20050123935 For use in multicolor/multiplexing assays; bioconjugation; kits |
06/09/2005 | US20050123934 Novel method for DNA amplification using DNA blocking probes |
06/09/2005 | US20050123929 Allelic nucleotide sequences coding protease inhibitor for use as diagnostic tool in detection cows with enhanced milk production; multiple ovulation and embryo transfer |
06/09/2005 | US20050123928 Using intergenic sequences between methyl mycolic acid synthase genes as diagnostic tool in detection of infection by grampositive bacteria |
06/09/2005 | US20050123908 Typing of human enteroviruses |
06/09/2005 | US20050123896 Drug screening a test agent, promoter silencing agents for treatment of cancer; histone deacetylase (HDAC) inhibitors like sodium butyrate and trichostatin A; modulate gene expression; bioassay, analysis; testing kits |
06/09/2005 | US20050123775 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization |
06/09/2005 | US20050123571 Modulation of apoptosis |
06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
06/09/2005 | US20050123557 AntiI-protozoal vaccine |
06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
06/09/2005 | US20050123546 Polynucleotides; engineered Type II anti-CD20 antibodies with altered glycosylation; vectors and host cells; treatment of B cell lymphomas |
06/09/2005 | US20050123538 nucleotide sequences that code human epidermal growth factor receptors, used for diagnosing and treating cancer |
06/09/2005 | US20050123523 Immunostimulatory nucleic acid molecules |
06/09/2005 | CA2547326A1 Novel muscle growth regulator |
06/09/2005 | CA2547033A1 Ntrk1 genetic markers associated with progression of alzheimer's disease |
06/09/2005 | CA2546659A1 Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
06/09/2005 | CA2546428A1 Compositions and methods for the diagnosis and treatment of tumor |
06/09/2005 | CA2546378A1 Mrna transfected antigen presenting cells |
06/09/2005 | CA2546287A1 Reduction of dermal scarring |
06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
06/09/2005 | CA2545610A1 Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression |
06/09/2005 | CA2541970A1 Gene silencing by using micro-rna molecules |
06/09/2005 | CA2541969A1 Real-time detection of nucleic acids and proteins |
06/08/2005 | EP1538481A1 A method of activating a silicon surface for subsequent patterning of molecules onto said surface |
06/08/2005 | EP1538222A1 Oligonucleotides for the detection of salmonella |
06/08/2005 | EP1538221A1 Oligonucleotides containing molecular rods |
06/08/2005 | EP1538206A2 Method for the complete chemical synthesis and assembly of genes and genomes |
06/08/2005 | EP1538162A2 Compositions for altering mucus secretion |
06/08/2005 | EP1538154A1 Quencher composition comprising anthraquinone moieties |
06/08/2005 | EP1537488A2 Systems and methods for predicting oligonucleotide melting temperatures (tms) |
06/08/2005 | EP1537228A2 Modulators of angiogenesis |
06/08/2005 | EP1537227A2 Method for efficient rna interference in mammalian cells |
06/08/2005 | EP1537210A1 Decoy-oligonucleotide-inhbition of cd40-expression |
06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
06/08/2005 | EP1537136A2 Promoters for regulation of gene expression in plant roots |
06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
06/08/2005 | EP1536814A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
06/08/2005 | EP1497469A4 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
06/08/2005 | CN1624153A Laver DNA fingerprint graphic and its forming process and application |
06/08/2005 | CN1624130A Fusion osmotic pressure regulating gent and protein their preparation process and application |
06/08/2005 | CN1624129A Specific promoter of root and its application |
06/08/2005 | CN1623999A Salt Du's algal nitrate transfer protein and its code sequence |
06/08/2005 | CN1623998A Gene and application related to synthesizing xanthogen glue |
06/08/2005 | CN1205341C Determination of man-shaped mycoplasma DNA sequence (5) specificity and its use |
06/08/2005 | CN1205335C Tumor death induction ligand gene, gene expression protein and is preparation method |
06/08/2005 | CN1205225C Human protein with cancer inhibiting function and its coding sequence |
06/07/2005 | US6904369 For drug screening stem cell factor (SCF) binding peptides; genetic engineering; crystal structure |
06/07/2005 | US6903246 Comprises nucleotide sequences coding dehydroascorbate reductase (DHAR) for use in reducing concentration of ascorbic acid in plants; drought tolerance |
06/07/2005 | US6903207 Nanoparticles having oligonucleotides attached thereto and uses therefor |
06/07/2005 | US6903206 First base sequence contains a cluster of at least four ribonucleotides modified to include a 2'-O methyl substitution to the ribofuranosyl moiety and the amplification oligonucleotide does not include a label |
06/07/2005 | US6903202 DNA encoding proteins that inhibit Hsp70 function |
06/07/2005 | US6903200 Transforming or transfecting a host cell with the recombinant vector, culturing such transformed or transfected cell under the conditions sufficient for expression of the human alpha 1 chain collagen protein |
06/07/2005 | US6903195 Obtaining a cell sample, lysing or permeabilizing the cells to antibodies, adding antibody to the cell sample, complexing antibody with CDN-1(a protein) and detecting the CDN protein |
06/07/2005 | US6903190 Nematode ATP synthase subunit E-like sequences |
06/07/2005 | US6903078 Applying wound healing agents comprising nucleotide sequences codes for platelet derived growth factors(PDGF), keratinocyte growth factors(KGF), insulin like growth factors(IGF) and insulin like growth factor binding proteins(IGFBP) |
06/07/2005 | US6903072 Polypeptide for use in the treatment of wounds, liver, inflammatory, kidney, lung and viral disorders |
06/07/2005 | US6902924 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals |
06/07/2005 | US6902923 For pharmacogenomic applications; cosmetics; nutriceuticals; fusion proteins |